Kronos Bio Announces Participation in 35th Annual Piper Sandler Healthcare ConferenceGlobeNewsWire • Monday
Kronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial ResultsGlobeNewsWire • 11/13/23
Kronos Bio Announces Plan to Optimize Resource Allocation, Restructure and Contain Costs Following Positive Preliminary Clinical Data from its KB-0742 Phase 1/2 StudyGlobeNewsWire • 11/02/23
Kronos Bio Presents Positive Preliminary Data from the Phase 1 Dose Escalation Portion of the Ongoing Phase 1/2 KB-0742 Study at the Connective Tissue Oncology Society Annual MeetingGlobeNewsWire • 11/02/23
Kronos Bio To Present Positive Preliminary Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 KB-0742 Study at the Connective Tissue Oncology Society Annual MeetingGlobeNewsWire • 10/27/23
Kronos Bio Presents Positive Preliminary Data from Phase 1 Dose Escalation Portion of Phase 1/2 KB-0742 Study at AACR-NCI-EORTCGlobeNewsWire • 10/13/23
Kronos Bio To Present Interim Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 KB-0742 Study at AACR-NCI-EORTC and Host Virtual Investor Event on October 13GlobeNewsWire • 10/04/23
Kronos Bio Announces Departure of Chief Financial Officer and Head of Corporate DevelopmentGlobeNewsWire • 08/17/23
Kronos Bio, Inc. (KRON) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research • 08/08/23
Kronos Bio Reports Recent Business Progress and Second-Quarter 2023 Financial ResultsGlobeNewsWire • 08/08/23
Kronos Bio Names Marc Besman, Ph.D., as Senior Vice President of Regulatory Affairs and Clinical Quality AssuranceGlobeNewsWire • 06/06/23
Kronos Bio, Inc. (KRON) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/10/23
Kronos Bio Reports Recent Business Progress and First-Quarter 2023 Financial ResultsGlobeNewsWire • 05/10/23
Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2022 Financial ResultsGlobeNewsWire • 03/15/23
Goldman Sachs Has 5 Stellar Stocks to Buy Under $10 With Up to 735% Upside Potential24/7 Wall Street • 03/04/23
Kronos Bio Announces Participation in 43rd Annual Cowen Health Care ConferenceGlobeNewsWire • 02/28/23
Kronos Bio Announces Discovery Collaboration with Genentech to Advance Novel Therapies Against Transcriptional Targets in OncologyGlobeNewsWire • 01/09/23
Here's Why Kronos Bio, Inc. (KRON) is Poised for a Turnaround After Losing 31% in 4 WeeksZacks Investment Research • 12/12/22